Issue 60, 2017

An electrochemical sensing platform for trace recognition and detection of an anti-prostate cancer drug flutamide in biological samples

Abstract

Developing simple, selective and sensitive platforms for anticancer drug analysis is of great importance in biomedical research. This study describes the fabrication of a ferrocene (FC) and multiwalled carbon nanotubes (MWCNTs) functionalized carbon paste electrode as a highly sensitive electrochemical sensor for the determination of anticancer drug flutamide in serum, plasma and urine samples. Scanning electron microscopy (SEM), cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS) and chronocoulometry methods were used to characterize the sensor. Electrochemical impedance studies revealed that the smaller Rct (charge transfer resistance) value was observed at FC/MWCNTs/CPE as compared to that of MWCNTs/CPE and CPE, which authenticates its good conductivity. The obtained sensor has a large specific area, high conductivity, good biocompatibility and fast redox properties. Various optimization parameters such as pH, accumulation time, deposition potential, scan rate and the effect of composite mixture on the electrochemical performance of the sensor were evaluated. A linear range from 0.1 to 110 μM for FT detection was obtained with a detection limit of 0.001 μM. Furthermore, the fabricated sensor has been utilized for estimation of FT in biological samples. This efficient strategy provides new insight into the design of novel flexible sensors for a wide range of applications in biosensing, bioelectronics, and clinical applications.

Graphical abstract: An electrochemical sensing platform for trace recognition and detection of an anti-prostate cancer drug flutamide in biological samples

Supplementary files

Article information

Article type
Paper
Submitted
14 Apr 2017
Accepted
19 Jul 2017
First published
02 Aug 2017
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2017,7, 37898-37907

An electrochemical sensing platform for trace recognition and detection of an anti-prostate cancer drug flutamide in biological samples

P. K. Brahman, L. Suresh, K. R. Reddy and B. J. S., RSC Adv., 2017, 7, 37898 DOI: 10.1039/C7RA04243D

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements